Logo image of LNZA

LANZATECH GLOBAL INC (LNZA) Stock Fundamental Analysis

NASDAQ:LNZA - US51655R1014 - Common Stock

21.6 USD
-0.42 (-1.91%)
Last: 8/26/2025, 8:00:00 PM
22.03 USD
+0.43 (+1.99%)
After Hours: 8/26/2025, 8:00:00 PM
Fundamental Rating

2

Overall LNZA gets a fundamental rating of 2 out of 10. We evaluated LNZA against 84 industry peers in the Commercial Services & Supplies industry. LNZA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LNZA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year LNZA has reported negative net income.
In the past year LNZA has reported a negative cash flow from operations.
In the past 5 years LNZA reported 4 times negative net income.
In the past 5 years LNZA always reported negative operating cash flow.
LNZA Yearly Net Income VS EBIT VS OCF VS FCFLNZA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

LNZA has a Return On Assets of -104.46%. This is amonst the worse of the industry: LNZA underperforms 91.67% of its industry peers.
Industry RankSector Rank
ROA -104.46%
ROE N/A
ROIC N/A
ROA(3y)-45.65%
ROA(5y)N/A
ROE(3y)-381.98%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LNZA Yearly ROA, ROE, ROICLNZA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

LNZA's Gross Margin of 45.30% is amongst the best of the industry. LNZA outperforms 80.95% of its industry peers.
LNZA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LNZA Yearly Profit, Operating, Gross MarginsLNZA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

5

2. Health

2.1 Basic Checks

LNZA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LNZA has less shares outstanding
The debt/assets ratio for LNZA is higher compared to a year ago.
LNZA Yearly Shares OutstandingLNZA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M
LNZA Yearly Total Debt VS Total AssetsLNZA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

LNZA has an Altman-Z score of 10.37. This indicates that LNZA is financially healthy and has little risk of bankruptcy at the moment.
LNZA's Altman-Z score of 10.37 is amongst the best of the industry. LNZA outperforms 91.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 10.37
ROIC/WACCN/A
WACC8.89%
LNZA Yearly LT Debt VS Equity VS FCFLNZA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M -50M 100M -100M

2.3 Liquidity

LNZA has a Current Ratio of 2.17. This indicates that LNZA is financially healthy and has no problem in meeting its short term obligations.
LNZA's Current ratio of 2.17 is fine compared to the rest of the industry. LNZA outperforms 72.62% of its industry peers.
A Quick Ratio of 2.17 indicates that LNZA has no problem at all paying its short term obligations.
The Quick ratio of LNZA (2.17) is better than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 2.17
Quick Ratio 2.17
LNZA Yearly Current Assets VS Current LiabilitesLNZA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

LNZA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -4803.23%.
Looking at the last year, LNZA shows a very negative growth in Revenue. The Revenue has decreased by -22.78% in the last year.
EPS 1Y (TTM)-4803.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7592.31%
Revenue 1Y (TTM)-22.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-7.43%

3.2 Future

LNZA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -6.27% yearly.
The Revenue is expected to grow by 18.28% on average over the next years. This is quite good.
EPS Next Y-78.91%
EPS Next 2Y-6.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-24.88%
Revenue Next 2Y18.28%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

LNZA Yearly Revenue VS EstimatesLNZA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 20M 40M 60M 80M
LNZA Yearly EPS VS EstimatesLNZA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -20 -40 -60

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LNZA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LNZA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LNZA Price Earnings VS Forward Price EarningsLNZA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LNZA Per share dataLNZA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

A cheap valuation may be justified as LNZA's earnings are expected to decrease with -6.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.27%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LNZA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LANZATECH GLOBAL INC

NASDAQ:LNZA (8/26/2025, 8:00:00 PM)

After market: 22.03 +0.43 (+1.99%)

21.6

-0.42 (-1.91%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners52.61%
Inst Owner Change-22.91%
Ins Owners1.76%
Ins Owner Change0%
Market Cap5.01B
Analysts45.71
Price Target193.8 (797.22%)
Short Float %N/A
Short Ratio2.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.15%
Min EPS beat(2)-3.59%
Max EPS beat(2)3.88%
EPS beat(4)1
Avg EPS beat(4)-17.23%
Min EPS beat(4)-49.87%
Max EPS beat(4)3.88%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-54.84%
Min Revenue beat(2)-59.75%
Max Revenue beat(2)-49.94%
Revenue beat(4)1
Avg Revenue beat(4)-33.66%
Min Revenue beat(4)-59.75%
Max Revenue beat(4)20.73%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9900%
PT rev (3m)9400%
EPS NQ rev (1m)-9900%
EPS NQ rev (3m)-11090.5%
EPS NY rev (1m)-6569.74%
EPS NY rev (3m)-6569.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-40.45%
Revenue NY rev (3m)-49.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 102.61
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-24.32
EYN/A
EPS(NY)-16.32
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS0.21
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -104.46%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.3%
FCFM N/A
ROA(3y)-45.65%
ROA(5y)N/A
ROE(3y)-381.98%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 93.85%
Cap/Sales 9.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.17
Quick Ratio 2.17
Altman-Z 10.37
F-Score3
WACC8.89%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4803.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7592.31%
EPS Next Y-78.91%
EPS Next 2Y-6.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-7.43%
Revenue Next Year-24.88%
Revenue Next 2Y18.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.81%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-145.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-142.08%
OCF growth 3YN/A
OCF growth 5YN/A